Strategic Alliances and Product Development in New Technology Firms: The Moderating Effect of Technological Capabilities
Babson College Entrepreneurship Research Conference (BCERC) 2008
Frontiers of Entrepreneurship Research 2008
15 Pages Posted: 5 Mar 2009
Abstract
We develop a model of product development based on the alliance portfolio of high technology firms. We draw on the capabilities perspective and argue that the impact of upstream, horizontal, and downstream alliances on the new firms' rate of product development depends on the degree of specialization of the firm's technological capabilities. Using a unique survey dataset of new technology firms in the German and UK biotechnology industries, the findings provide support for our model and demonstrate that technological capabilities are an important factor that mitigates the benefits and risks of alliances for the product development process of new technology firms. We discuss implications for the alliance literature.
Keywords: Entrepreneurship
JEL Classification: M13
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Do Equity Financing Cycles Matter?: Evidence from Biotechnology Alliances
By Alexander Tsai and Josh Lerner
-
Do Equity Financing Cycles Matter? Evidence from Biotechnology Alliances
By Alexander Tsai and Josh Lerner
-
By Ilan Guedj and David S. Scharfstein
-
By Ilan Guedj and David S. Scharfstein
-
Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality
By Sean Nicholson, Patricia M. Danzon, ...
-
Financial Contracting in Biotech Strategic Alliances
By David T. Robinson and Toby Stuart
-
Contractibility and the Design of Research Agreements
By Ulrike Malmendier and Josh Lerner
-
Contractibility and the Design of Research Agreements
By Ulrike Malmendier and Josh Lerner
-
Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances
By Patricia M. Danzon, Sean Nicholson, ...